Calliditas Therapeutics ABCalliditas Therapeutics ABCalliditas Therapeutics AB

Calliditas Therapeutics AB

No trades
See on Supercharts

CALT fundamentals

Calliditas Therapeutics AB earnings per share and revenue

CALT earnings per share for the last quarter are -0.07 USD whereas the estimation was -0.18 USD which accounts for 63.87% surprise. Company revenue for the same period amounts to 43.50 M USD despite the estimated figure of 33.70 M USD. Estimated earnings per share for the next quarter are -0.16 USD, and revenue is expected to reach 36.43 M USD. Also watch annual changes over time to get a bigger picture of CALT earnings per share and revenue dynamics.

Next report date
Report period
EPS estimate
Revenue estimate
EPS
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Revenue
‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise